More Flu News: GlaxoSmithKline is sending out feelers about shipping some vaccine our way, although it would be limited quantity:

GSK said it was talking with FDA officials about the possibility of granting Fluarix speedy approval for sale in the U.S. this season -- although it is unlikely this will make a significant difference to the supply picture.

The vast majority of the company's flu vaccine is already committed to customers under long-term contract, leaving perhaps only around 200,000 doses available for shipment elsewhere.